IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF

IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF

The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates), kits comprising said immunogenic compositions and uses thereof. Immunogenic compositions of the present invention will typically comprise at le...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DUTTA, Kaushik, SINGH, Suddham, KIM, Jin-hwan, MORAN, Justin Keith, YANG, YuYing
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DUTTA, Kaushik
SINGH, Suddham
KIM, Jin-hwan
MORAN, Justin Keith
YANG, YuYing
description The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates), kits comprising said immunogenic compositions and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions. La présente invention concerne de nouvelles compositions immunogènes comprenant des antigènes (glycoconjugués) saccharidiques capsulaires de Streptococcus pneumoniae conjugués, des kits comprenant lesdites compositions immunogènes et des utilisations associées. Les compositions immunogènes de la présente invention comprennent généralement au moins un glycoconjugué d'un sérotype de S. pneumoniae que l'on ne trouve pas dans PREVNAR®, SYNFLORIX® et/ou PREVNAR 13®. L'invention concerne également la vaccination de patients humains, en particulier des nourrissons et des personnes âgées, contre des infections pneumococciques à l'aide desdites nouvelles compositions immunogènes.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024224266A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024224266A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024224266A13</originalsourceid><addsrcrecordid>eNqNjMEKwjAQRHvxIOo_BDwLWqX3JdkmKyYp2YRehFIknkQL9f8xiB8gDMx7MMyyupK1yXmNjqSQ3naeKZJ3_JVATE4XdOekIaISEjpOFwiCQUoDgRQKcJHKARdQIjGyiAYD-nZdLe7jY86bX6-qbYtRml2eXkOep_GWn_k99L7e16e6pGngcPxv9QHL9DOr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF</title><source>esp@cenet</source><creator>DUTTA, Kaushik ; SINGH, Suddham ; KIM, Jin-hwan ; MORAN, Justin Keith ; YANG, YuYing</creator><creatorcontrib>DUTTA, Kaushik ; SINGH, Suddham ; KIM, Jin-hwan ; MORAN, Justin Keith ; YANG, YuYing</creatorcontrib><description>The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates), kits comprising said immunogenic compositions and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions. La présente invention concerne de nouvelles compositions immunogènes comprenant des antigènes (glycoconjugués) saccharidiques capsulaires de Streptococcus pneumoniae conjugués, des kits comprenant lesdites compositions immunogènes et des utilisations associées. Les compositions immunogènes de la présente invention comprennent généralement au moins un glycoconjugué d'un sérotype de S. pneumoniae que l'on ne trouve pas dans PREVNAR®, SYNFLORIX® et/ou PREVNAR 13®. L'invention concerne également la vaccination de patients humains, en particulier des nourrissons et des personnes âgées, contre des infections pneumococciques à l'aide desdites nouvelles compositions immunogènes.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241031&amp;DB=EPODOC&amp;CC=WO&amp;NR=2024224266A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25555,76308</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241031&amp;DB=EPODOC&amp;CC=WO&amp;NR=2024224266A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DUTTA, Kaushik</creatorcontrib><creatorcontrib>SINGH, Suddham</creatorcontrib><creatorcontrib>KIM, Jin-hwan</creatorcontrib><creatorcontrib>MORAN, Justin Keith</creatorcontrib><creatorcontrib>YANG, YuYing</creatorcontrib><title>IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF</title><description>The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates), kits comprising said immunogenic compositions and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions. La présente invention concerne de nouvelles compositions immunogènes comprenant des antigènes (glycoconjugués) saccharidiques capsulaires de Streptococcus pneumoniae conjugués, des kits comprenant lesdites compositions immunogènes et des utilisations associées. Les compositions immunogènes de la présente invention comprennent généralement au moins un glycoconjugué d'un sérotype de S. pneumoniae que l'on ne trouve pas dans PREVNAR®, SYNFLORIX® et/ou PREVNAR 13®. L'invention concerne également la vaccination de patients humains, en particulier des nourrissons et des personnes âgées, contre des infections pneumococciques à l'aide desdites nouvelles compositions immunogènes.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjMEKwjAQRHvxIOo_BDwLWqX3JdkmKyYp2YRehFIknkQL9f8xiB8gDMx7MMyyupK1yXmNjqSQ3naeKZJ3_JVATE4XdOekIaISEjpOFwiCQUoDgRQKcJHKARdQIjGyiAYD-nZdLe7jY86bX6-qbYtRml2eXkOep_GWn_k99L7e16e6pGngcPxv9QHL9DOr</recordid><startdate>20241031</startdate><enddate>20241031</enddate><creator>DUTTA, Kaushik</creator><creator>SINGH, Suddham</creator><creator>KIM, Jin-hwan</creator><creator>MORAN, Justin Keith</creator><creator>YANG, YuYing</creator><scope>EVB</scope></search><sort><creationdate>20241031</creationdate><title>IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF</title><author>DUTTA, Kaushik ; SINGH, Suddham ; KIM, Jin-hwan ; MORAN, Justin Keith ; YANG, YuYing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024224266A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DUTTA, Kaushik</creatorcontrib><creatorcontrib>SINGH, Suddham</creatorcontrib><creatorcontrib>KIM, Jin-hwan</creatorcontrib><creatorcontrib>MORAN, Justin Keith</creatorcontrib><creatorcontrib>YANG, YuYing</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DUTTA, Kaushik</au><au>SINGH, Suddham</au><au>KIM, Jin-hwan</au><au>MORAN, Justin Keith</au><au>YANG, YuYing</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF</title><date>2024-10-31</date><risdate>2024</risdate><abstract>The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates), kits comprising said immunogenic compositions and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions. La présente invention concerne de nouvelles compositions immunogènes comprenant des antigènes (glycoconjugués) saccharidiques capsulaires de Streptococcus pneumoniae conjugués, des kits comprenant lesdites compositions immunogènes et des utilisations associées. Les compositions immunogènes de la présente invention comprennent généralement au moins un glycoconjugué d'un sérotype de S. pneumoniae que l'on ne trouve pas dans PREVNAR®, SYNFLORIX® et/ou PREVNAR 13®. L'invention concerne également la vaccination de patients humains, en particulier des nourrissons et des personnes âgées, contre des infections pneumococciques à l'aide desdites nouvelles compositions immunogènes.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2024224266A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T03%3A16%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DUTTA,%20Kaushik&rft.date=2024-10-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024224266A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true